top of page
Search
Rapport Therapeutics – RAP-219 Phase 2 Clinical Trial
Executive Summary Rapport has a phase 2 (P2) readout upcoming for RAP-219, a TARPy8 AMPA receptor modulator. The preclinical results are...
Aug 27, 20256 min read
bottom of page